Media coverage
1Media coverage
Title 2/5/16 - U.S. FDA Approves Expanded Use of Bristol-Myers Squibbâ??s Daklinza (daclatasvir) for Additional Challenging-to-treat Patients with Genotype 1 or Genotype 3 Chronic Hepatitis C Media name/outlet Pharmacy Choice Country United States Date 2/6/16 Persons Fred Poordad